Tag: BioNTech

The German biotechnology firm BioNTech is on the verge of a significant strategic achievement, having successfully navigated the primary hurdle ...

The European biotech landscape is poised for a significant transformation as BioNTech approaches the final stages of its planned acquisition ...

The landscape of mRNA technology is undergoing a significant transformation. BioNTech, the Mainz-based biotech firm renowned for its COVID-19 vaccine, ...

A prolonged period of negotiations and strategic maneuvering within the German biotech sector has culminated in a definitive resolution. Shareholders ...

Investor attention is sharply focused on today's CureVac shareholder meeting, which represents a critical juncture for BioNTech. The assembly will ...

The formal dissolution of one of biotech's most prominent partnerships has rattled investors, with Pfizer's complete exit from its BioNTech ...

A surprising development emerged in mid-November when pharmaceutical giant Pfizer divested 54.7% of its stake in BioNTech, triggering a significant ...

A seismic development has rocked BioNTech's stock valuation following the complete divestment of Pfizer's substantial shareholding. The long-standing pandemic partner ...

The German biotech firm BioNTech finds itself navigating turbulent waters following a significant divestment by its longtime collaborator. In a ...

After a prolonged period of disappointing its shareholders, the pioneering coronavirus vaccine developer is showing signs of a potential resurgence. ...